442 Entecavir 10 mg is consistently superior to lamivudine at 48 weeks across multiple baseline HBV disease characteristics in lamivudine-refractory patients
- 31 December 2004
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 40, 131
- https://doi.org/10.1016/s0168-8278(04)90442-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: